206 related articles for article (PubMed ID: 6189937)
1. Expression of passively transferred immunity against an established tumor depends on generation of cytolytic T cells in recipient. Inhibition by suppressor T cells.
Mills CD; North RJ
J Exp Med; 1983 May; 157(5):1448-60. PubMed ID: 6189937
[TBL] [Abstract][Full Text] [Related]
2. The antimetastatic function of concomitant antitumor immunity. II. Evidence that the generation of Ly-1+2+ effector T cells temporarily causes the destruction of already disseminated tumor cells.
Dye ES
J Immunol; 1986 Feb; 136(4):1510-5. PubMed ID: 3080526
[TBL] [Abstract][Full Text] [Related]
3. Ly-1+2- suppressor T cells inhibit the expression of passively transferred antitumor immunity by suppressing the generation of cytolytic T cells.
Mills CD; North RJ
Transplantation; 1985 Feb; 39(2):202-8. PubMed ID: 3155882
[TBL] [Abstract][Full Text] [Related]
4. Specificity of the T cells that mediate and suppress adoptive immunotherapy of established tumors.
Dye ES; North RJ
J Leukoc Biol; 1984 Jul; 36(1):27-37. PubMed ID: 6234371
[TBL] [Abstract][Full Text] [Related]
5. Ly 1+2- suppressor T cells down-regulate the generation of Ly 1-2+ effector T cells during progressive growth of the P815 mastocytoma.
North RJ; Dye ES
Immunology; 1985 Jan; 54(1):47-56. PubMed ID: 3156088
[TBL] [Abstract][Full Text] [Related]
6. Adoptive immunization against an established tumor with cytolytic versus memory T cells. Immediate versus delayed onset of regression.
Dye ES; North RJ
Transplantation; 1984 Jun; 37(6):600-5. PubMed ID: 6427998
[TBL] [Abstract][Full Text] [Related]
7. T cell-mediated immunosuppression as an obstacle to adoptive immunotherapy of the P815 mastocytoma and its metastases.
Dye ES; North RJ
J Exp Med; 1981 Oct; 154(4):1033-42. PubMed ID: 6457075
[TBL] [Abstract][Full Text] [Related]
8. Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells.
North RJ; Bursuker I
J Exp Med; 1984 May; 159(5):1295-311. PubMed ID: 6232335
[TBL] [Abstract][Full Text] [Related]
9. Tumor-specific suppressor T-cells which inhibit the in vitro generation of cytolytic T-cells from immune and early tumor-bearing host spleens.
Bear HD
Cancer Res; 1986 Apr; 46(4 Pt 1):1805-12. PubMed ID: 2936451
[TBL] [Abstract][Full Text] [Related]
10. Failure of specific adoptive immunotherapy owing to survival and outgrowth of variant cells.
Hines DL
Cancer Immunol Immunother; 1989; 28(4):241-7. PubMed ID: 2495177
[TBL] [Abstract][Full Text] [Related]
11. In vitro expression of secondary antitumor immunity by in vitro tumor-sensitized T cells: inhibition by tumor-induced suppressor T cells.
Kaymakcalan Z; Spitalny GL; Bursuker I
Cancer Immunol Immunother; 1987; 25(2):69-74. PubMed ID: 2959361
[TBL] [Abstract][Full Text] [Related]
12. T cell suppressors of antitumor immunity. The production of Ly-1-,2+ suppressors of delayed sensitivity precedes the production of suppressors of protective immunity.
DiGiacomo A; North RJ
J Exp Med; 1986 Oct; 164(4):1179-92. PubMed ID: 2944983
[TBL] [Abstract][Full Text] [Related]
13. The antimetastatic function of concomitant antitumor immunity. I. Host Ly-1+2+ effector T cells prevent the enumeration of metastatic tumor cells in a biological assay.
Dye SE
J Immunol; 1986 Feb; 136(4):1504-9. PubMed ID: 3080525
[TBL] [Abstract][Full Text] [Related]
14. Adoptive immunotherapy of a newly induced sarcoma: immunologic characteristics of effector cells.
Shu S; Rosenberg SA
J Immunol; 1985 Oct; 135(4):2895-903. PubMed ID: 2411817
[TBL] [Abstract][Full Text] [Related]
15. Adoptive immunotherapy of established tumors. Acquisition of radioresistance by tumor-specific T cells after passive transfer into tumor-bearing recipients.
Dunn PL; North RJ
Int J Cancer; 1994 May; 57(4):592-7. PubMed ID: 8181862
[TBL] [Abstract][Full Text] [Related]
16. Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression.
Uyttenhove C; Maryanski J; Boon T
J Exp Med; 1983 Mar; 157(3):1040-52. PubMed ID: 6187879
[TBL] [Abstract][Full Text] [Related]
17. The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cells.
Mulé JJ; Yang J; Shu S; Rosenberg SA
J Immunol; 1986 May; 136(10):3899-909. PubMed ID: 2871106
[TBL] [Abstract][Full Text] [Related]
18. Gamma-irradiation facilitates the expression of adoptive immunity against established tumors by eliminating suppressor T cells.
North RJ
Cancer Immunol Immunother; 1984; 16(3):175-81. PubMed ID: 6231095
[TBL] [Abstract][Full Text] [Related]
19. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone.
Cerundolo V; Lahaye T; Horvath C; Zanovello P; Collavo D; Engers HD
Eur J Immunol; 1987 Feb; 17(2):173-8. PubMed ID: 3030766
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the involvement of cells from donor and recipient mice in adoptive transfer of antitumor immunity.
Lee FH; Currie D; Hwang KM
Cancer Res; 1984 Dec; 44(12 Pt 1):5491-8. PubMed ID: 6208997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
